Dopamine D2 Receptor Antagonism Suppresses Tau Aggregation and Neurotoxicity

Biological Psychiatry - Netherlands
doi 10.1016/j.biopsych.2012.08.027
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Differential Modulation of Reinforcement Learning by D2 Dopamine and NMDA Glutamate Receptor Antagonism

Journal of Neuroscience
Neuroscience
2014English

Effects of Dopamine D2/D3 Receptor Antagonism on Human Planning and Spatial Working Memory

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2017English

Antagonism of Dopamine D2 Receptor/ -Arrestin 2 Interaction Is a Common Property of Clinically Effective Antipsychotics

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Typical and Atypical Antipsychotics Do Not Differ Markedly in Their Reversibility of Antagonism of the Dopamine D2 Receptor

International Journal of Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2013English

D1 and D2 Dopamine Receptor mRNA in Rat Brain.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Cortical Ionotropic Glutamate Receptor Antagonism Protects Against Methamphetamine-Induced Striatal Neurotoxicity

Neuroscience
Neuroscience
2011English

Dopamine Receptor Antagonism by the Novel Antianxiety Drug, Buspirone

Journal of Neuroscience
Neuroscience
1983English

Specific Knockdown of the D2 Long Dopamine Receptor Variant

NeuroReport
Neuroscience
2012English

Novel and Potent Dopamine D2 Receptor (D2R) Go-Protein Biased Agonists

ACS Pharmacology & Translational Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy